文献速递前列腺增生与排尿功能障碍

确定医保受益者中经皮胫神经刺激诱导治疗的真实世界定义

Determining a Real-world Definition of Percutaneous Tibial Nerve Stimulation Induction Therapy in Medicare Beneficiaries With Overactive Bladder.
PubMed 文献 · Urology · 2026-01-29

本研究基于2015至2020年100%医保按服务收费受益者样本,回顾性分析41,962例接受PTNS治疗的特发性膀胱过度活动症患者,通过直方图和敏感性分析确定真实世界诱导方案为15周内11次治疗,32.6%患者完成,高于标准方案的7.9%。年龄≥85岁、非白人、合并症多和衰弱者完成率更低。

要点

  • 真实世界诱导PTNS定义为15周内11次治疗,完成率32.6%。
  • 标准诱导方案完成率仅7.9%,真实世界定义完成率约为其三倍。
  • 高龄、非白人、合并症多和衰弱与完成率降低相关。

核心结论

  • 本研究确定新的诱导PTNS定义(15周内11次治疗),完成人数是标准方案的3倍。
  • 该定义可用于未来该人群PTNS利用研究。

研究设计与样本

  • 回顾性队列研究,使用2015至2020年100%医保按服务收费受益人样本。
  • 共41,962例因特发性膀胱过度活动症接受诱导PTNS治疗的受益人。

主要发现

  • 直方图众数、第75百分位和敏感性分析得出诱导PTNS方案为15周内11次治疗。
  • 32.6%受益人完成该队列定义方案,而完成标准方案者仅7.9%。
  • 年龄≥85岁较66-74岁完成率更低(aRR 0.92)。
  • 非白人种族完成率更低(aRR 0.90)。
  • 合并症指数CCI≥4较CCI为0完成率更低(aRR 0.80),衰弱者较不衰弱者更低(aRR 0.93)。

关键数值与推荐

  • 诱导PTNS真实世界定义:15周内11次治疗。
  • 完成率:队列定义32.6%,标准方案7.9%。

临床怎么用

  • 临床可参考15周内11次作为更现实的诱导PTNS疗程定义。
  • 对高龄、非白人、合并症多和衰弱患者需关注完成率可能较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine real-world utilization of induction percutaneous tibial nerve stimulation (PTNS) among Medicare beneficiaries to determine a more realistic, population-specific definition of induction PTNS in older adults, given poor overall adherence with the standard induction PTNS schedule. METHODS: This is a retrospective cohort study of a 100% sample of fee-for-service Medicare beneficiaries undergoing PTNS treatment for idiopathic OAB from 2015 to 2020. Histograms and sensitivity analyses were explored to yield an optimal definition of induction PTNS based on real-world utilization. An adjusted multivariable modified Poisson regression was then created to determine factors associated with completing this cohort-based definition. RESULTS: A total of 41,962 beneficiaries underwent induction PTNS. The histogram's mode and 75th percentile and sensitivity analyses yielded an induction PTNS schedule of 11 treatments in 15 weeks, completed by 32.6% of beneficiaries, compared to 7.9% completing the standard schedule. Beneficiaries who were older (≥85 years, aRR 0.92 vs 66-74 years), non-white race (aRR 0.90), more comorbid (CCI ≥4, aRR 0.80 vs CCI of 0), and more frail (aRR 0.93 vs not frail) were less likely to complete the cohort-based definition. CONCLUSION: This study determined a new definition for induction PTNS (11 sessions in 15 weeks), completed by 3 times as many beneficiaries as the standard schedule. These findings support a more realistic definition that can be used for future research on PTNS utilization in this population.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Nseyo U, Wang L, Crow A, et al. Determining a Real-world Definition of Percutaneous Tibial Nerve Stimulation Induction Therapy in Medicare Beneficiaries With Overactive Bladder. Urology. 2026. PMID: 41620125. doi:10.1016/j.urology.2026.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。